Bailard’s Viemed Healthcare VMD Stock Holding History

Bailard’s Portfolio VMD Stock Details VMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-31,747	Closed	-$255K	–	849
2024 Q4	$255K	Buy	+31,747	New	+$275K	0.01%	626
2024 Q1	–	Sell	-32,022	Closed	-$251K	–	823
2023 Q4	$251K	Buy	+32,022	New	+$232K	0.01%	602

Other funds holding VMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

FCM

Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

KLP

Kent Lake PR Anasco, Puerto Rico $198M AUM 5.21% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bailard's VMD Position: Q1 2025 in Review

Bailard sold out of Viemed Healthcare (VMD) in Q1 2025, closing a stake of 31,747 shares — an estimated $255K sold.

Bailard first reported a position in VMD in Q4 2023 and held it in 2 quarters. The position peaked at $255K in Q4 2024. 139 funds tracked by Wall St. Rank hold VMD as of Q1 2025.

Bailard reported no remaining Viemed Healthcare position as of Q1 2025 after selling out during the quarter.
Bailard sold 31,747 Viemed Healthcare shares in Q1 2025, an estimated $255K.
Bailard first reported a position in Viemed Healthcare in Q4 2023 and held it in 2 quarters.
Bailard's Viemed Healthcare position peaked at $255K in Q4 2024.
139 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2025.

Based on Bailard's 13F filing for Q1 2025, filed 2 May 2025.